Abstract:Selective degradation of disease-causing proteins using proteolysis targeting chimeras (PROTACs) has gained great attention, thanks to its several advantages over traditional therapeutic modalities. Despite the advances made so far, the structural chemical complexity of PROTACs poses challenges in their synthetic approaches. PROTACs are typically prepared through a convergent approach, first synthesizing two fragments separately (target protein and E3 ligase ligands) and then coupling them to produce a fully assembled PROTAC. The amidation reaction represents the most common coupling exploited in PROTACs synthesis. Unfortunately, the overall isolated yields of such synthetic procedures are usually low due to one or more purification steps to obtain the final PROTAC with acceptable purity. In this work, we focused our attention on the optimization of the final amidation step for the synthesis of an anti-SARS-CoV-2 PROTAC by investigating different amidation coupling reagents and a range of alternative solvents, including ionic liquids (ILs). Among the ILs screened, [OMIM][ClO 4 ] emerged as a successful replacement for the commonly used DMF within the HATU-mediated amidation reaction, thus allowing the synthesis of the target PROTAC under mild and sustainable conditions in very high isolated yields. With the optimised conditions in hand, we explored the scalability of the synthetic approach and the substrate scope of the reaction by employing different E3 ligase ligand (VHL and CRBN)-based intermediates containing linkers of different lengths and compositions or by using different target protein ligands. Interestingly, in all cases, we obtained high isolated yields and complete conversion in short reaction times.

Chemoselective Synthesis of Lenalidomide-Based PROTAC Library Using Alkylation Reaction.

A Modular Chemistry Platform for the Development of a Cereblon E3 Ligase‐based Partial PROTAC Library

A One-Pot Photocatalytic Triazole-Based Linkerology for PROTACs

Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase Ligands

Design, synthesis, and biological characterization of proteolysis targeting chimera (PROTACs) for the Ataxia telangiectasia and RAD3-related (ATR) kinase

Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design.

Stereoselective synthesis of allele-specific BET inhibitors

Design and Synthesis of New Lenalidomide Analogs Via Suzuki Cross‐coupling Reaction

Novel Amphiphilic PROTAC with Enhanced Pharmacokinetic Properties for ALK Protein Degradation

Discovery of Alkenyl Oxindole as a Novel PROTAC Moiety for Targeted Protein Degradation via CRL4 Recruitment

Potent and Preferential Degradation of CDK6 Via Proteolysis Targeting Chimera Degraders

Distinct Amino Acid-Based PROTACs Target Oncogenic Kinases for Degradation in Non-Small Cell Lung Cancer (NSCLC)

Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis

Design, synthesis and biological evaluation of Lenalidomide derivatives as tumor angiogenesis inhibitor

Designed, synthesized and biological evaluation of proteolysis targeting chimeras (PROTACs) as AR degraders for prostate cancer treatment

Alkenyl Oxindole is a Novel PROTAC Moiety That Recruits the CRL4DCAF11 E3 Ubiquitin Ligase Complex for Targeted Protein Degradation

Discovery of orally bioavailable ALK PROTACs based Ceritinib against ALK positive cancers

Design, Synthesis and Bioactivity Evaluation of Self-Assembled PROTACs Based on Multi-Target Kinase Inhibitors

Feasible Column Chromatography-Free, Multi-Gram Scale Synthetic Process of VH032 Amine, Which Could Enable Rapid PROTAC Library Construction.

Design, Synthesis, and Activity Evaluation of BRD4 PROTAC Based on Alkenyl Oxindole-DCAF11 Pair